Compounding Pharmacy · Stafford, TX · 503A

Casa Pharma RX Review

Casa Pharma RX is a 503A licensed sterile compounding pharmacy in Stafford, Texas, operating a state-of-the-art cleanroom built to USP 797 and USP 800 standards. Sources APIs exclusively from FDA-registered suppliers. Its site describes patient-specific sterile compounding for licensed prescribers and does not name specific GLP-1 products or telehealth partners.

Casa Pharma RX names no GLP-1 products on its own site, but OnlineSemaglutide.org and Breeze Meds list it among their pharmacies. A cleanroom built to USP 797 meets a sterile-compounding standard; it is not an outside accreditation, and how PCAB accreditation works covers that difference.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

503AState pharmacy licenseUSP 797 sterile compounding
Location: Stafford, TX
States licensed: 1
6.0/10
★★★☆☆3/5

Editorial score out of 10 · methodology

Telehealth Providers Sourcing From This Pharmacy

These telehealth brands are reported to fulfill some or all compounded GLP-1 prescriptions through Casa Pharma RX. Sourcing arrangements can change over time.

8.1/ 10
Partner

RxSpan MD

Best for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options

★★★★☆4.1/5

Editorial score · methodology

$249/mosemaglutide
$329/motirzepatide
CompoundedSemaglutideTirzepatideGHK-CuGlutathioneLegitScript Verified
Get StartedRead full RxSpan MD review →
7.1/ 10
Partner

Bodybuilding Health+

Best for: fitness-brand compounded GLP-1 with hormone and performance programs

★★★★☆3.6/5

Editorial score · methodology

$179/mosemaglutide
starting dose
$209/motirzepatide
starting dose
CompoundedSemaglutideTirzepatideGHK-CuGlutathioneLegitScript Verified
Get StartedRead full Bodybuilding Health+ review →
8.1/ 10

Pallas Health

Best for: the most complete public disclosure of pharmacies and prescribing physicians we have found

★★★★☆4.1/5

Editorial score · methodology

$199/4 wkssemaglutide
billed per 4 weeks
$299/4 wkstirzepatide
billed per 4 weeks
SemaglutideTirzepatideOrforglipronNAD+
7.8/ 10

Care Bare Rx

Best for: LGBTQ+-inclusive compounded GLP-1 telehealth

★★★★☆3.9/5

Editorial score · methodology

$199/mosemaglutide
starting dose
$199/motirzepatide
starting dose
SemaglutideTirzepatideNAD+
7.7/ 10

Synergy Rx

Best for: broadest drug catalog in the Lion MD white-label cluster

★★★★☆3.9/5

Editorial score · methodology

$199/mosemaglutide
starting dose
$349/motirzepatide
starting dose
SemaglutideTirzepatide
7.4/ 10

Breeze Meds

Best for: compounded GLP-1 access with named prescribers and 4-pharmacy network

★★★★☆3.7/5

Editorial score · methodology

$199/mosemaglutide
“starting at” price
$399/motirzepatide
after intro offer
SemaglutideTirzepatideNAD+
7.3/ 10

OnlineSemaglutide.org

Best for: shoppers who want injection or tablet GLP-1 options at one dose-independent price

★★★★☆3.7/5

Editorial score · methodology

$219/mosemaglutide
$299/motirzepatide
SemaglutideTirzepatide

Certifications & Compliance

All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.

State pharmacy license
Licensed by the pharmacy's home state board of pharmacy. All US pharmacies must hold a state license at minimum.
503A
Traditional patient-specific compounding pharmacy under Section 503A — compounds individual prescriptions and is regulated primarily by its state board of pharmacy.
USP 797 sterile compounding
United States Pharmacopeia compounding standards (USP <795> non-sterile, <797> sterile, <800> hazardous drugs) — the quality chapters state boards enforce for compounded preparations.

Drugs Produced

Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].

Semaglutide
Compounded semaglutide produced
Tirzepatide
Compounded tirzepatide produced

States Licensed (1)

TX

Regulatory Actions

No public FDA enforcement actions or recalls are on file in our records for Casa Pharma RX. Regulatory status can change — verify with the FDA and your state board of pharmacy before relying on this information.

Weight Loss Rankings Score Breakdown

Accreditation & Compliance6/10
Regulatory Standing9/10
State Coverage0/10
GLP-1 Production10/10
Track Record5/10

Scores are independently researched. See our methodology for details.

Medium confidence · Pharmacy details last verified November 2026 · How we verify provider data

Frequently Asked Questions

Casa Pharma RX is a 503A compounding pharmacy based in Stafford, TX. It operates under state board of pharmacy licensure. We are not aware of any recent public FDA enforcement actions against the pharmacy, though compounding pharmacy regulatory history can change. Always verify current status with your state board of pharmacy.
Casa Pharma RX is headquartered in Stafford, TX. The pharmacy is licensed to ship to 1 US states.
Casa Pharma RX produces compounded semaglutide and compounded tirzepatide in addition to other compounded preparations. As a 503A pharmacy, it dispenses compounded medications in response to individual patient prescriptions under state board of pharmacy oversight.
503A pharmacies prepare compounded medications for individual patients in response to specific prescriptions and are regulated primarily by state boards of pharmacy under USP <797> sterile compounding standards. 503B outsourcing facilities register directly with the FDA, follow current Good Manufacturing Practices (cGMP), and can produce compounded medications in larger batches without patient-specific prescriptions. 503B facilities are subject to FDA inspection.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources & methodology (as of November 2026)
  1. 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.